Comparison of a single intravitreal injection of bevacizumab versus triamcinolone acetonide as primary treatment for diffuse diabetic macular oedema

Acta Ophthalmol. 2012 Mar;90(2):e160-1. doi: 10.1111/j.1755-3768.2010.02098.x. Epub 2011 Apr 6.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Multicenter Study

MeSH terms

  • Angiogenesis Inhibitors / therapeutic use*
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Bevacizumab
  • Case-Control Studies
  • Diabetic Retinopathy / drug therapy*
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Intravitreal Injections
  • Macula Lutea / pathology
  • Macular Edema / drug therapy*
  • Male
  • Middle Aged
  • Retrospective Studies
  • Treatment Outcome
  • Triamcinolone Acetonide / therapeutic use*
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity / physiology

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • Glucocorticoids
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Triamcinolone Acetonide